LLY Total debt
Total debt at Lilly (Eli) rose to $42.5B in fiscal 2025, the highest in the 5 years reported, from $33.6B in 2024.
Current debt plus long-term debt, both as filed. Names that do not tag current debt show long-term debt only, and say so.
SOURCE: us-gaap:LongTermDebtNoncurrent + us-gaap:DebtCurrent · EDGAR CompanyFacts · CIK 59478 · EDGAR ↗ · FY2021–FY2025 · ANNUAL
History AS FILED · DERIVATION SHOWN WHERE DERIVED
| Fiscal year | Current debt | Long-term debt | Total |
|---|---|---|---|
| FY2025 | $1.6B | $40.9B | $42.5B |
| FY2024 | $5.1B | $28.5B | $33.6B |
| FY2023 | $6.9B | $18.3B | $25.2B |
| FY2022 | $1.5B | $14.7B | $16.2B |
| FY2021 | $1.5B | $15.3B | $16.9B |
Cross-checks touching this measure FROM THE FILING REVIEW
◐ PARTLYtotal debt
The quoted figures do not map one-for-one onto a filed line on this page; carried as partly supported.
FY2025 10-K · FULL RECONCILIATION →More SAME DATA, OTHER VIEWS
Total debt across coverage → · LLY company view →
Revenue · Net income · Operating cash flow · Cash & equivalents · Total assets · Shareholders' equity · Return on equity · Days sales outstanding
Not investment advice. Every figure on this page is an XBRL fact from the issuer's own SEC filings or an arithmetic over such facts with the method shown. No forecast is made; no posture is expressed.